240 Outcomes with Novel Oral Anticoagulants(NOACs) Bleeding in Atrial Fibrillation (AF) Patients at Liverpool Hospital – a Single Centre Experience

NOACs are widely used for AF stroke prevention but Factor-Xa-Inhibitor(FXaI) reversing agent is not widely available and expensive.

Source: Heart, Lung and Circulation - November 8, 2020 Category: Cardiology Authors: D. Nguyen, G. Femia, P. Motum, D. Hsu, S. Ng, S. Lo Source Type: research